Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against Staphylococcus pseudintermedius in Dogs
Pathogens · 2024
DOI: 10.3390/pathogens13121121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Ji-Soo Jeong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine (BK21 FOUR Program), Chungnam National University, 99 Daehak-ro, Daejeon 34131, Republic of Korea. Hauptthemen laut MEDLINE: Staphylococcus, Microbial Sensitivity Tests, Amoxicillin, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry (IPET), Ministry of Agriculture, Food and Rural Affairs (MAFRA).
Abstract (Originalsprache)
Antibiotic resistance in bacteria from companion animals poses significant public health risks. Prudent antibiotic use, particularly through pharmacokinetics/pharmacodynamics modeling, is crucial for minimizing resistance. We investigated the pharmacokinetics/pharmacodynamics of amoxicillin (AMX) against Staphylococcus pseudintermedius. A pharmacokinetic study was conducted on healthy dogs subcutaneously injected with a dose of 15 mg/kg AMX. The antibacterial efficacy of AMX was evaluated against a standard strain from animals (KCTC 3344) and clinical isolates from dogs (B-2, B-7, and B-8), with minimum inhibitory concentrations (MICs) of 0.25, 0.5, 64, and 16 μg/mL, respectively. The half-life of AMX was 7 h, allowing for extended drug efficacy. The time above MIC (%T > MIC) values indicated that the AMX concentrations were maintained above MICs of the two susceptible strains (KCTC 3344 and B-2) for more than 80% of the time when dosed at a one-day interval, suggesting an effective treatment. The area under the curve over 24 h/MIC ratios confirmed the bacteriostatic, bactericidal, and bacterial eradication effects of AMX against S. pseudintermedius strains, except for B-7 (the most resistant strain). These results support improved clinical dosing strategies for AMX against S. pseudintermedius infections in dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine (BK21 FOUR Program), Chungnam National University, 99 Daehak-ro, Daejeon 34131, Republic of Korea.
- Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Science, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea.
- Inhalation Toxicology, Jeongeup Campus, KIT, Jeongeup-si 580-185, Republic of Korea.
ORCID-Profile: Ji-Soo Jeong, Jeong-Won Kim, Jin-Hwa Kim, Eun-Hye Chung, Je-Won Ko, Tae-Won Kim
Förderung
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry (IPET)
- Ministry of Agriculture, Food and Rural Affairs (MAFRA)
Zitieren
APA
Jeong, J. S., Kim, J. W., Kim, J. H., Kim, C. Y., Chung, E. H., Boo, S. Y., Lee, S. H., Ko, J. W., & Kim, T. W. (2024). Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against Staphylococcus pseudintermedius in Dogs. Pathogens. https://doi.org/10.3390/pathogens13121121
Vancouver
Jeong JS, Kim JW, Kim JH, Kim CY, Chung EH, Boo SY, et al. Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against Staphylococcus pseudintermedius in Dogs. Pathogens. 2024. doi:10.3390/pathogens13121121
BibTeX
@article{Jeong2024,
author = {Jeong, Ji-Soo and Kim, Jeong-Won and Kim, Jin-Hwa and Kim, Chang-Yeop and Chung, Eun-Hye and Boo, So-Young and Lee, Su-Ha and Ko, Je-Won and Kim, Tae-Won},
title = {Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against Staphylococcus pseudintermedius in Dogs},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13121121}
}
EUVIMED